Radius Health Inc
(NASDAQ : RDUS)

( )
RDUS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.45%201.801.2%$542.05m
GILDGilead Sciences, Inc.
-1.21%73.270.9%$465.10m
BIIBBiogen Inc.
-2.95%320.411.3%$380.15m
CELGCelgene Corporation
-0.65%82.411.2%$337.48m
ILMNIllumina, Inc.
-2.60%313.103.5%$332.96m
REGNRegeneron Pharmaceuticals, Inc.
-1.36%389.832.6%$235.91m
VRTXVertex Pharmaceuticals Incorporated
-1.79%175.691.9%$230.46m
ALXNAlexion Pharmaceuticals, Inc.
-0.53%125.892.0%$220.48m
SRPTSarepta Therapeutics, Inc.
-3.30%134.2216.4%$169.84m
AAgilent Technologies, Inc.
-1.95%64.471.5%$159.28m
BMRNBioMarin Pharmaceutical Inc.
-0.58%103.224.4%$142.60m
LGNDLigand Pharmaceuticals Incorporated
-4.84%187.5223.3%$115.84m
EXASExact Sciences Corporation
-2.88%61.6425.3%$102.69m
NKTRNektar Therapeutics
-2.76%48.195.6%$101.86m
NBIXNeurocrine Biosciences, Inc.
-2.24%112.015.1%$98.21m

Company Profile

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The firm's lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes abaloparatide transdermal patch for potential use in osteoporosis and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Waltham, MA.